Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||
| Net Income | -3,451 | -621 | -8,190 |
| Depreciation Amortization | 752 | 752 | 1,670 |
| Accounts receivable | -125 | -14 | N/A |
| Other Working Capital | 1,525 | 703 | -800 |
| Other Operating Activity | -2,187 | -2,350 | 110 |
| Operating Cash Flow | $-3,487 | $-1,530 | $-7,210 |
| Cash Flows From Investing Activities | |||
| Other Investing Activity | 0 | 0 | 1,360 |
| Investing Cash Flow | $N/A | $0 | $1,360 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 42,587 | 2,483 | 2,470 |
| Financing Cash Flow | $42,587 | $2,483 | $2,470 |
| Beginning Cash Position | 1,641 | 1,641 | 5,010 |
| End Cash Position | 40,741 | 2,594 | 1,640 |
| Net Cash Flow | $39,100 | $953 | $-3,370 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,487 | -1,530 | -7,210 |
| Free Cash Flow | -3,487 | -1,530 | -7,210 |